LSC - 2021 - Effect of elexacaftor-tezacaftor-ivacaftor on pulmonary and endothelial function in a patient with advanced cystic fibrosis Source: Virtual Congress 2021 – Clinical effects of CFTR modulatory therapy and lung inflammation in children with cystic fibrosis Year: 2021
Role of IL-11 in vascular function of pulmonary fibrosis patients Source: International Congress 2019 – Pulmonary hypertension with lung diseases and experimental pulmonary hypertension Year: 2019
The lung clearance index correlates with markers of pulmonary deterioration in patients with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: physiotherapy, exercise and lung function in adults and children Year: 2013
Pulmonary arterial hypertension and advanced lung disease in cystic fibrosis patients Source: Eur Respir J 2007; 30: Suppl. 51, 387s Year: 2007
Role of JAK2/STAT3 pathway in vascular function of pulmonary fibrosis patients Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015
Pulmonary hypertension in cystic fibrosis patients Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Endothelial dysfunction in cystic fibrosis: imbalance NOS/arginase? Source: Annual Congress 2007 - Cystic fibrosis lung disease: from diagnosis to end-stage Year: 2007
Improvement in pulmonary function after IV antibiotic treatment in cystic fibrosis patients Source: Eur Respir J 2002; 20: Suppl. 38, 342s Year: 2002
VEGF gene transfer enhances fibrosis but improves pulmonary hemodynamics in experimental pulmonary fibrosis Source: Annual Congress 2008 - Animal models of pulmonary fibrosis: mechanisms and therapies Year: 2008
Evaluation of functional capacity and pulmonary functions during acute pulmonary exacerbation in children with cystic fibrosis Source: Virtual Congress 2020 – Exercise tolerance and functional status across respiratory diseases Year: 2020
Association between diffusion capacity and endothelial function in patients with idiopathic pulmonary fibrosis Source: International Congress 2018 – Sarcoidosis, interstitial lung diseases and various clinical problems Year: 2018
Effects of flow-dependent and threshold PEP on lung functions in cystic fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 332s Year: 2003
Clinical characteristics and pulmonary function in patients with pulmonary fibrosis assessed for lung transplant Source: Annual Congress 2010 - Pre-operative evaluation and post-operative problems after lung transplantation Year: 2010
Increased arterial stiffness in adult patients with cystic fibrosis Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools Year: 2008
Assessment of nutritional status in patients with idiopathic pulmonary fibrosis Source: International Congress 2016 – Long-term oxygen therapy, noninvasive ventilation, and other clinical variables in chronic lung diseases Year: 2016
The effectiveness of pulmonary rehabilitation in patients diagnosed with interstitial pulmonary fibrosis Source: Virtual Congress 2020 – The multiple facets of pulmonary rehabilitation and chronic respiratory care Year: 2020
Effect of recurrent growth of aspergillus on lung function in paediatric population with cystic fibrosis (CF) Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011
Titrated oxygen requirement and prognostication in idiopathic pulmonary fibrosis Source: Eur Respir J 2012; 39: 359-365 Year: 2012